Cannabis (Medical Marijuana) Treatment for Motor and Non–Motor Symptoms of Parkinson Disease: An Open-Label Observational Study

@article{Lotan2014CannabisM,
  title={Cannabis (Medical Marijuana) Treatment for Motor and Non–Motor Symptoms of Parkinson Disease: An Open-Label Observational Study},
  author={I. Lotan and T. Treves and Y. Roditi and R. Djaldetti},
  journal={Clinical Neuropharmacology},
  year={2014},
  volume={37},
  pages={41–44}
}
ObjectiveThe use of cannabis as a therapeutic agent for various medical conditions has been well documented. However, clinical trials in patients with Parkinson disease (PD) have yielded conflicting results. The aim of the present open-label observational study was to assess the clinical effect of cannabis on motor and non–motor symptoms of PD. MethodsTwenty-two patients with PD attending the motor disorder clinic of a tertiary medical center in 2011 to 2012 were evaluated at baseline and 30… Expand
105 Citations
Medical Cannabis in Parkinson Disease: Real-Life Patients' Experience
  • 30
  • PDF
Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms?
  • 18
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
  • 142
  • Highly Influenced
  • PDF
Evidence for the use of cannabinoids in Parkinson’s disease
  • 7
Cannabis in Parkinson's Disease: The Patients' View.
Cannabinoids in the Treatment of Parkinson’s Disease
  • 2
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 22 REFERENCES
Cannabis for dyskinesia in Parkinson disease: A randomized double-blind crossover study
  • 99
Marijuana for parkinsonian tremor.
  • 66
  • PDF
Survey on cannabis use in Parkinson's disease: Subjective improvement of motor symptoms
  • 116
  • PDF
Survey of Australians using cannabis for medical purposes
  • 100
The endocannabinoid system as a target for the treatment of neurodegenerative disease
  • 133
  • PDF
Cannabinoids in the treatment of glaucoma.
  • 158
Blockade of Cannabinoid Type 1 Receptors Augments the Antiparkinsonian Action of Levodopa without Affecting Dyskinesias in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Rhesus Monkeys
  • 96
  • PDF
...
1
2
3
...